A very modest win: Generic Health gets 2% cut to Bayer’s $25 million damages
8 November 2018
Last year, Bayer was awarded more than $25 million (plus interest and indemnity costs) against Generic Health in the first Federal Court award of damages for pharmaceutical patent infringement.
Read on